Since serum levels of IL-6 may reflect the activity of AML, it is possible that the elevated serum BAFF concentrations found in untreated patients and statistically higher in active NR, compared to patients with CR, may be related to the growth of myeloid cells. This evidence concerns the gene TNFSF13B and acute myeloid leukemia.